# Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax

> **NCT04555694** · PHASE4 · COMPLETED · sponsor: **Thomas Chester, OD** · enrollment: 30 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Cyclosporine
- **DRUG:** Loteprednol Etabonate
- **DRUG:** Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert

## Key facts

- **NCT ID:** NCT04555694
- **Lead sponsor:** Thomas Chester, OD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-02-16
- **Final completion:** 2022-02-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555694, "Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04555694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*